肿瘤浸润淋巴细胞（TIL）疗法行业现状与发展趋势白皮书

Investment Rating - The report indicates a positive investment outlook for the Tumor-Infiltrating Lymphocyte (TIL) therapy industry, highlighting its rapid development and potential for commercialization [3][5]. Core Insights - TIL therapy has shown significant advantages in treating solid tumors, including high specificity, safety, broad-spectrum anti-cancer effects, and durable efficacy. It is positioned as a competitive and promising direction in the field of immunotherapy for solid tumors [3][4]. - The industry is driven by factors such as market demand, technological innovation, government policy support, and increased investment, leading to rapid growth in the TIL therapy market globally, including in China [5]. Summary by Sections Section 1: Overview of Antitumor Treatment Market - The report provides an analysis of global and Chinese cancer incidence, emphasizing the prevalence of solid tumors and the need for effective treatment options [36][41]. - It discusses various antitumor treatment methods, including surgery, chemotherapy, targeted therapy, and immunotherapy, highlighting the evolution of treatment approaches over time [39][40]. Section 2: Introduction to TIL Therapy - TIL therapy has a rich development history and is recognized for its advantages in treating solid tumors [14]. - The report outlines the challenges faced by the TIL therapy industry, including technical, clinical application, regulatory, and commercialization challenges [14]. Section 3: Analysis of Market and Pipeline - The report analyzes the existing TIL therapy products and ongoing clinical trials, with a focus on Lifileucel, its clinical trial history, and the challenges it faces [17]. - It also provides insights into the pipeline of TIL therapies under development, indicating a robust future for the industry [17]. Section 4: Future Development Trends of TIL Therapy Market - The report identifies key drivers for the TIL therapy market, including increasing clinical demand for antitumor drugs and advancements in cancer treatment technologies [41][47]. - It discusses the performance of the capital market related to TIL therapy, indicating a positive trend in investment and market growth [41][47].